Seeking Alpha

IMUC
ImmunoCellular Therapeutics, Ltd. - NYSEMKT

4/24/2014, 3:37 AM ET
Quote & Analysis Breaking News StockTalk
imuc chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There is research on this stock available only to PRO subscribers.
Other Articles
IMUC vs. ETF Alternatives
Company Description

ImmunoCellular Therapeutics Limited is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.